D-1122-2019 Class III Terminated
FDA drug recall D-1122-2019 was initiated by AVKARE Inc. on Apr 3, 2019 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications; 18 month long term stability study (manufacturer) The recall status is terminated (terminated May 7, 2020). Affected quantity: 397 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 17, 2019
- Initiation Date
- Apr 3, 2019
- Termination Date
- May 7, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 397 bottles
Product description
Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablets, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478 --- NDC 42291-795-30
Reason for recall
Failed Impurities/Degradation Specifications; 18 month long term stability study (manufacturer)
Distribution pattern
AZ, CO
Code information
Lots: 201916 Exp. 08/2019; 20092 Exp. 08/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1122-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026